Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-01-06
1989-09-12
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 546 65, A61K 3147
Patent
active
048660710
ABSTRACT:
A new antineoplastic substance denominated "pancratistatin". Methods of isolating natural and synthetic pancratistatin and 7-deoxynarciclasine and the pharmaceutically acceptable derivatives thereof to make a pharmaceutical preparation therefrom and methods for treating a host afflicted with a neoplasm with said preparations.
REFERENCES:
patent: 3588993 (1971-06-01), Okamoto et al.
Keck et al., "Synthetic Studies on Lycoricidine", Tetra. Let., vol. 22, No. 28, pp. 2615-2618 (1981).
Mondon et al., "Zur Kenntnis des Narciclasins", Chem. Ber., 108, pp. 445-463 (1975).
Pettit et al., "Isolation and Structure of Pancratistan", Journ. Chem. Soc. Chem. Comm., pp. 1693-1694 (1984).
Piozzi, "Narciclasine and Narciprimine", Tetra., vol. 24, pp. 1119-1131 (1968).
Keek et al., Tetrahedron Letters, vol. (22), No. 28, pp. 2615-2618 (1981).
Piozzi et al., Tetrahedron, vol. 24, pp. 1119-1131 (1968).
Arizona Board of Regents
Mybeck Richard R.
Rozycki Andrew G.
Sutto Anton H.
LandOfFree
Method of inhibiting leukemias and sarcomas in a mammalian host does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting leukemias and sarcomas in a mammalian host, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting leukemias and sarcomas in a mammalian host will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-916498